EyePoint Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
We're on. We're going to get started. I'm Jennifer Kim, a biopharma and biotech analyst at Cantor. And I'm looking forward to hosting EyePoint Pharmaceuticals for this fireside chat. We have with us George Elston, CFO of EyePoint .
George, thanks for joining us.
Yeah. Thank you, Jennifer, and I appreciate the opportunity to tell the EyePoint story here at Cantor. We appreciate the invite and looking forward to the discussion.
Okay. Looking forward to it. Maybe to start off, can you introduce and give an overview of the company?
Sure. So EyePoint -- we're based in Watertown, Massachusetts, and we are focused on serious eye disease, leveraging our Durasert technology, which is a well-established technology for sustained delivery of treatments to the eye.
I think we'll
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |